RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis

BACKGROUND: To elucidate clinicopathological characteristics of non-small-cell lung carcinoma (NSCLC) cases carrying RET rearrangements causing oncogenic fusions to identify responders to therapy with RET tyrosine kinase inhibitors. METHODS: We investigated 1874 patients with carcinomas, including 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuta, K, Kohno, T, Yoshida, A, Shimada, Y, Asamura, H, Furuta, K, Kushima, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960615/
https://www.ncbi.nlm.nih.gov/pubmed/24504365
http://dx.doi.org/10.1038/bjc.2014.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960615/
https://www.ncbi.nlm.nih.gov/pubmed/24504365
http://dx.doi.org/10.1038/bjc.2014.36

Ejemplares similares